These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9331606
1. Necrotising fasciitis associated with invasive group A streptococcal infections in England and Wales. Monnickendam MA, McEvoy MB, Blake WA, Gaworzewska ET, Hallas G, Tanna A, Efstratiou A, George RC. Adv Exp Med Biol; 1997; 418():87-9. PubMed ID: 9331606 [No Abstract] [Full Text] [Related]
2. Characterisation of group A streptococci from necrotising fasciitis cases in Gloucestershire, United Kingdom. Efstratiou A, George RC, Tanna A, Hookey JV, Caugant D, Holm SE, Kriz P, Martin D, Upton M, Cartwright KA. Adv Exp Med Biol; 1997; 418():91-3. PubMed ID: 9331607 [No Abstract] [Full Text] [Related]
3. Two clusters of invasive Streptococcus pyogenes infection in England. Barnham M, Weightman N, Chapman S, Efstratiou A, George RC, Stanley J. Adv Exp Med Biol; 1997; 418():67-9. PubMed ID: 9331601 [No Abstract] [Full Text] [Related]
4. Clinical and microbiological characteristics of severe group A streptococcal infections in Italy. von Hunolstein C, Suligoi B, Pataracchia M, Scopetti F, Recchia S, Greco D, Orefici G. Adv Exp Med Biol; 1997; 418():79-81. PubMed ID: 9331604 [No Abstract] [Full Text] [Related]
5. Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections. Müller-Alouf H, Geoffroy C, Geslin P, Bouvet A, Felten A, Günther E, Ozegowski JH, Reichardt W, Alouf JE. Adv Exp Med Biol; 1997; 418():241-3. PubMed ID: 9331642 [No Abstract] [Full Text] [Related]
9. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE. N Engl J Med; 1996 Aug 22; 335(8):547-54. PubMed ID: 8684408 [Abstract] [Full Text] [Related]
11. Group A streptococcal invasive disease in England and Wales. Efstratiou A, George RC, Gaworzewska ET, Hallas G, Tanna A, Blake WA, Monnickendam MA, McEvoy MB. Adv Exp Med Biol; 1997 Aug 22; 418():207-10. PubMed ID: 9331633 [No Abstract] [Full Text] [Related]
12. Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia. Linder KA, Alkhouli L, Ramesh M, Alangaden GA, Kauffman CA, Miceli MH. J Infect; 2017 May 22; 74(5):450-455. PubMed ID: 28237623 [Abstract] [Full Text] [Related]
13. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. Imöhl M, Reinert RR, Ocklenburg C, van der Linden M. FEMS Immunol Med Microbiol; 2010 Apr 22; 58(3):389-96. PubMed ID: 20146737 [Abstract] [Full Text] [Related]
15. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Svensson N, Oberg S, Henriques B, Holm S, Källenius G, Romanus V, Giesecke J. Scand J Infect Dis; 2000 Apr 22; 32(6):609-14. PubMed ID: 11200369 [Abstract] [Full Text] [Related]
16. Group A Streptococcal bacteraemia. Experience at King Fahad Medical City in Riyadh, Saudi Arabia. Al-Khadidi FJ, AlSheheri MA, AlFawaz TS, Enani MA, AlAqeel AA, AlShahrani DA. Saudi Med J; 2017 Oct 22; 38(10):1034-1037. PubMed ID: 28917068 [Abstract] [Full Text] [Related]